1. Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 Tumors.
- Author
-
Weidemann, Sören, Noori, Nessar Ahmad, Lennartz, Maximilian, Reiswich, Viktor, Dum, David, Menz, Anne, Chirico, Viktoria, Hube-Magg, Claudia, Fraune, Christoph, Bawahab, Ahmed Abdulwahab, Bernreuther, Christian, Simon, Ronald, Clauditz, Till S., Sauter, Guido, Hinsch, Andrea, Kind, Simon, Jacobsen, Frank, Steurer, Stefan, Minner, Sarah, and Burandt, Eike
- Subjects
GRANULOSA cell tumors ,INHIBIN ,PANCREATIC acinar cells ,TESTIS tumors ,CELL tumors ,ADRENAL cortex - Abstract
As a result of its expression in corresponding normal cell types, inhibin alpha (INHA) is used as an immunohistochemical marker for adrenocortical neoplasms and testicular or ovarian sex cord stromal tumors. However, other tumors can also express INHA. To comprehensively determine INHA expression in cancer, a tissue microarray containing 15,012 samples from 134 different tumor types and subtypes was analyzed by immunohistochemistry. INHA positivity was found in 72 of 134 tumor categories, including 26 categories with ≥1 strongly positive case. A moderate to strong INHA positivity was found in 100% of 37 granulosa cell tumors of the ovary, 100% of 43 other sex cord stromal tumors of the ovary/testis, 100% of 31 granular cell tumors, 78.5% of 28 adenomas, 44% of 25 carcinomas of the adrenal cortex, and 46.7% of 15 pancreatic acinar cell carcinomas. At least a weak INHA positivity was seen in <33% of cases of 46 additional tumor entities. In summary, these data support the use of INHA antibodies for detecting sex cord stromal tumors, granular cell tumors, and adrenocortical neoplasms. Since INHA can also be found in other tumor entities, INHA immunohistochemistry should only be considered as a part of any panel for the distinction of tumor entities. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF